ArticleScientific reports2017

Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression.

Yang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.